Cellectar Biosciences, Inc. (CLRB)
2.355
-0.16
(-6.18%)
USD |
NASDAQ |
Jun 09, 16:00
2.375
+0.02
(+0.85%)
After-Hours: 20:00
Cellectar Biosciences SG&A Expense (Quarterly) : 2.787M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | 26.68M |
| Forum Markets, Inc. | 7.492M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Savara, Inc. | 15.57M |